Tecfidera and Tooth loss - a phase IV clinical study of FDA data

Summary:

Tooth loss is reported as a side effect among people who take Tecfidera (dimethyl fumarate), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Ampyra, and have Gait disturbance.

The phase IV clinical study analyzes which people have Tooth loss when taking Tecfidera. It is created by eHealthMe based on reports of 129,391 people who have side effects when taking Tecfidera from the FDA, and is updated regularly.

What is Tecfidera?

Tecfidera has active ingredients of dimethyl fumarate. It is often used in multiple sclerosis. eHealthMe is studying from 129,627 Tecfidera users. Check the latest studies of Tecfidera.

What is Tooth loss?

Tooth loss is found to be associated with 1,095 drugs and 942 conditions by eHealthMe. Check the latest studies of Tooth loss.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

129,391 people reported to have side effects when taking Tecfidera.
Among them, 72 people (0.06%) have Tooth loss.

Among these 72 people:

How long have people been on Tecfidera when they have Tooth loss? *

What is the gender of people who have Tooth loss when taking Tecfidera? *

female: 79.66 %
male: 20.34 %

What is the age of people who have Tooth loss when taking Tecfidera? *

What are other drugs people take besides Tecfidera? *

What are other side effects people have besides Tooth loss? *

Skin Blushing/flushing (a sudden reddening of the face, neck): 11 people, 15.28%
Fall: 10 people, 13.89%
Tooth Fracture: 9 people, 12.50%
Nausea (feeling of having an urge to vomit): 8 people, 11.11%
Weight Decreased: 6 people, 8.33%
Hair Loss: 6 people, 8.33%
Headache (pain in head): 5 people, 6.94%
Balance Disorder: 5 people, 6.94%
Dental Caries: 5 people, 6.94%
Tooth Abscess (pus formation in tooth): 5 people, 6.94%

What are the existing conditions these people have? *

Gait Disturbance: 8 people, 11.11%
Migraine (headache): 4 people, 5.56%
Pain: 3 people, 4.17%
Migraine Without Aura (headache without neurological problems): 2 people, 2.78%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 2.78%
Depression: 2 people, 2.78%
Muscle Spasms (muscle contraction): 2 people, 2.78%
Urinary Tract Infection: 1 person, 1.39%
Fatigue (feeling of tiredness): 1 person, 1.39%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 1.39%

* Approximation only. Some reports may have incomplete information.

Do you take Tecfidera and have Tooth loss?

- Check whether Tooth loss is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tecfidera:

Tecfidera (129,627 reports)

Tooth loss treatments and more:

Tooth loss (33,880 reports)

Browse all side effects of Tecfidera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tooth loss:

Tooth loss (1,095 drugs)

Browse all the conditions that are associated with Tooth loss:

Tooth loss (942 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dimethyl fumarate (the active ingredients of Tecfidera) and Tecfidera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.